Treatment of latent M. tuberculosis infection and use of antiretroviral therapy to prevent tuberculosis

Even with treatment of HIV with antiretroviral therapy (ART), the risk of tuberculosis (TB) reactivation remains higher in HIV-infected than HIV-uninfected persons. In this issue of the JCI, Ganatra et al. explored TB reactivation in the context of ART using TB and simian immunodeficiency virus-coin...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	The Journal of clinical investigation Jg. 130; H. 10; S. 5102 - 5104
Hauptverfasser:	Sterling, Timothy R., Lin, Philana Ling
Format:	Journal Article
Sprache:	Englisch
Veröffentlicht:	United States American Society for Clinical Investigation 01.10.2020
Schlagworte:	Animals Antiretroviral agents CD4-Positive T-Lymphocytes Comorbidity Drug therapy Health aspects Highly active antiretroviral therapy HIV Infections - complications HIV Infections - drug therapy Macaca mulatta Monkeys Rifamycins Rifapentine Simian Acquired Immunodeficiency Syndrome - drug therapy Simian Immunodeficiency Virus T cells Tuberculosis Tuberculosis - drug therapy Tuberculosis - prevention & control
ISSN:	0021-9738, 1558-8238, 1558-8238
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!